Dr. Evandro de Azambuja and colleagues at the Jules Bordet Institute, Brussels, Belgium, told the conference that his work, which involved 2887 patients, showed that women who had a body mass index (BMI) of more than 30kg/m2 had poorer outcomes in terms of disease-free and overall survival. “Our data once more stress the global problem of obesity,” he said.
Dr. de Azambuja and colleagues studied patients who were taking part in an international phase III trial (BIG 2-98) which compared two docetaxel regimes with two anthracycline regimes in patients with node-positive breast cancer (where the cancer has spread to the lymph nodes). Obesity was found in 19% of all patients enrolled in this trial. “We found that 5-year disease-free survival in non-obese patients was significantly higher than in the obese group,” he said. “75.9% of the non-obese patients were disease-free after 5 years as compared to 70% of those who were obese. In addition, the 5-year overall survival was 87.5% in the non-obese patients compared to 82.9% in the obese patients.
“Reports estimate that obesity and physical inactivity account for 25-30% of the incidence of post-menopausal breast cancer,” said Dr. de Azambuja.
“To date, published studies have not specified the type of chemotherapy being used and therefore cannot be generalised to current practice. Studies are also inconsistent in the collection of BMI data and the time point of measurement, the cut-off points or BMI criteria, and the stage of disease,” he said
The scientists now plan to further analyse their data to look at hormonal status and co-morbidities (the effect of additional diseases the patients may have) in order to better understand exactly what role obesity plays in the prognosis of the patients.
“There are some reports showing that obese patients are generally under-treated with chemotherapy (lower dose intensity) and we are currently looking at this important issue in our study. Patients included in this analysis belong to a trial in which they will be followed for at least ten years from the date of their original randomisation,” said Dr. de Azambuja.
“We will be continuing to analyse the data to see whether there are changes over time. Several other researchers have demonstrated that obesity is linked to worse prognosis in breast cancer patients, and obesity has been linked with many other diseases, such as diabetes and cardiovascular disease. Politicians need urgently to put in place programmes to reduce the incidence of obesity and its consequences.”
In another presentation to the conference, Dr. Elisabetta Rapiti, of the Geneva Cancer Registry, Geneva, Switzerland, said that her research had found that obese breast cancer patients presented more often with advanced disease than did those who were not obese. “Given that obesity has reached endemic proportions around the world, it is important that we try to understand its effects in all health areas,” she said. “We need urgently to find ways of managing breast cancer in obese women.”
Dr. Rapiti and colleagues studied 1100 women diagnosed with invasive breast cancer in the canton of Geneva between 2003 and 2005. For 460 of these patients, information on weight and height was available, and the scientists were able to calculate individual BMIs. They then compared diagnostic characteristics – stage at diagnosis, the palpability of the primary tumour, use of ultrasound and MRI, etc – of obese women with those of non-obese patients.
They found that obese women presented significantly more often with stage 3-4 disease, and that they were less likely to have undergone ultrasound or MRI examinations. They also experienced more surgical delay and prolonged hospital stay after surgery.
The more advanced stage at diagnosis could be due to the larger breast size of obese women, with more fatty tissue, which can lead to difficulties in palpating the primary tumour and the axillary lymph nodes. “Our study confirms this hypothesis,” said Dr. Rapiti.
“Also, obese women may be more reluctant to undergo physical examination because of embarrassment about their weight. Doctors may be more judgemental towards patients who are significantly overweight, and severe obesity may need specially adapted equipment which is not always available,” she said.
“We need to educate women and doctors that self-examination and clinical examination may be less reliable in obese women, and think of strategies to prevent advanced disease at diagnosis for this growing group of patients.”
Mary Rice | alfa
Discovery shows promise for treating Huntington's Disease
05.08.2020 | Ecole Polytechnique Fédérale de Lausanne
Carbon monoxide improves endurance performance
05.08.2020 | Universität Bayreuth
Scientists at the Fraunhofer Institute for Laser Technology ILT have come up with a striking new addition to contact stamping technologies in the ERDF research project ScanCut. In collaboration with industry partners from North Rhine-Westphalia, the Aachen-based team of researchers developed a hybrid manufacturing process for the laser cutting of thin-walled metal strips. This new process makes it possible to fabricate even the tiniest details of contact parts in an eco-friendly, high-precision and efficient manner.
Plug connectors are tiny and, at first glance, unremarkable – yet modern vehicles would be unable to function without them. Several thousand plug connectors...
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.
Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women...
Traditional single-cell sequencing methods help to reveal insights about cellular differences and functions - but they do this with static snapshots only...
“Core-shell” clusters pave the way for new efficient nanomaterials that make catalysts, magnetic and laser sensors or measuring devices for detecting electromagnetic radiation more efficient.
Whether in innovative high-tech materials, more powerful computer chips, pharmaceuticals or in the field of renewable energies, nanoparticles – smallest...
An international research team with Prof. Cornelia Denz from the Institute of Applied Physics at the University of Münster develop for the first time light fields using caustics that do not change during propagation. With the new method, the physicists cleverly exploit light structures that can be seen in rainbows or when light is transmitted through drinking glasses.
Modern applications as high resolution microsopy or micro- or nanoscale material processing require customized laser beams that do not change during...
23.07.2020 | Event News
21.07.2020 | Event News
07.07.2020 | Event News
06.08.2020 | Earth Sciences
06.08.2020 | Power and Electrical Engineering
06.08.2020 | Life Sciences